NO983850L - Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanser - Google Patents

Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanser

Info

Publication number: NO983850L
Authority: NO; Norway
Prior art keywords: adjuvants; peptides; surface preparation; pharmaceutical surface; immunomodulation based
Prior art date: 1996-02-24

Application number

NO983850A

Other languages

English (en)

Norwegian (no)

Other versions

NO983850D0 (no

Inventor

Walter Schmidt

Max Birnstiel

Peter Steinlein

Michael Buschle

Tamos Schweighoffer

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-24

Filing date

1998-08-21

Publication date

1998-10-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27215945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO983850(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-02-24 Priority claimed from DE19607044A external-priority patent/DE19607044A1/de

1996-09-19 Priority claimed from DE19638313A external-priority patent/DE19638313C2/de

1996-11-25 Priority claimed from DE19648687A external-priority patent/DE19648687A1/de

1998-08-21 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

1998-08-21 Publication of NO983850D0 publication Critical patent/NO983850D0/no

1998-10-21 Publication of NO983850L publication Critical patent/NO983850L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO983850A 1996-02-24 1998-08-21 Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanser NO983850L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE19607044A DE19607044A1 (de)	1996-02-24	1996-02-24	Tumorvakzine und Verfahren zu ihrer Herstellung
DE19638313A DE19638313C2 (de)	1996-09-19	1996-09-19	Pharmazeutische Zusammensetzung für die Immunmodulation
DE19648687A DE19648687A1 (de)	1996-11-25	1996-11-25	Pharmazeutische Zusammensetzung für die Immunmodulation
PCT/EP1997/000828 WO1997030721A1 (de)	1996-02-24	1997-02-21	Pharmazeutische zusammensetzung für die immunmodulation beruhend auf peptiden und adjuvantien

Publications (2)

Publication Number	Publication Date
NO983850D0 NO983850D0 (no)	1998-08-21
NO983850L true NO983850L (no)	1998-10-21

Family

ID=27215945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO983850A NO983850L (no)	1996-02-24	1998-08-21	Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanser

Country Status (35)

Country	Link
US (1)	US7105162B1 (cs)
EP (1)	EP0881906B2 (cs)
JP (1)	JP4184433B2 (cs)
KR (1)	KR100457647B1 (cs)
CN (1)	CN1177610C (cs)
AR (1)	AR005945A1 (cs)
AT (1)	ATE274350T1 (cs)
AU (1)	AU722264B2 (cs)
BG (1)	BG63682B1 (cs)
BR (1)	BR9707694A (cs)
CA (1)	CA2243559C (cs)
CO (1)	CO4600681A1 (cs)
CZ (1)	CZ295396B6 (cs)
DE (1)	DE59711873D1 (cs)
DK (1)	DK0881906T4 (cs)
EE (1)	EE04481B1 (cs)
ES (1)	ES2225951T5 (cs)
HK (1)	HK1017257A1 (cs)
HR (1)	HRP970100B1 (cs)
HU (1)	HU224410B1 (cs)
ID (1)	ID16038A (cs)
IL (1)	IL125361A (cs)
MY (1)	MY119276A (cs)
NO (1)	NO983850L (cs)
NZ (1)	NZ332020A (cs)
PE (1)	PE55398A1 (cs)
PL (1)	PL189413B1 (cs)
PT (1)	PT881906E (cs)
RO (1)	RO119344B1 (cs)
RS (1)	RS50101B (cs)
SI (1)	SI0881906T2 (cs)
SK (1)	SK284582B6 (cs)
TR (1)	TR199801649T2 (cs)
TW (1)	TW585774B (cs)
WO (1)	WO1997030721A1 (cs)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS50101B (sr)	1996-02-24	2009-01-22	Boehringer Ingelheim International Gmbh.,	Farmaceutski preparati za imunomodulaciju
DE19803453A1 (de) *	1998-01-30	1999-08-12	Boehringer Ingelheim Int	Vakzine
DE69936355T2 (de) *	1998-02-25	2008-02-21	The Government Of The United States, As Represented By The Secretary Of The Army	Verwendung von Hautpenetrationsförderern und für die Zerstörung der oberen Hautschichten geeigneten Mitteln zur Erhöhung der transkutanen Immunantwort
WO1999053912A1 (en) *	1998-04-20	1999-10-28	Torrey Pines Institute For Molecular Studies	Topical immunostimulation to induce langerhans cell migration
DK2204186T3 (en) *	1999-02-17	2016-07-18	Csl Ltd	Immunogenic complexes, and related methods
DE19909503A1 (de) *	1999-03-04	2000-09-07	Boehringer Ingelheim Int	Tumorassoziiertes Antigen
US6809179B1 (en)	1999-08-04	2004-10-26	Boehringer Ingelheim International Gmbh	Tumor-associated antigen (R11)
AT408721B (de)	1999-10-01	2002-02-25	Cistem Biotechnologies Gmbh	Pharmazeutische zusammensetzung enthaltend ein antigen
AT409085B (de) *	2000-01-28	2002-05-27	Cistem Biotechnologies Gmbh	Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
US20020009491A1 (en) *	2000-02-14	2002-01-24	Rothbard Jonathan B.	Compositions and methods for enhancing drug delivery across biological membranes and tissues
AT409762B (de) *	2000-04-13	2002-11-25	Cistem Biotechnologies Gmbh	Verfahren zur identifizierung von zytokin sekretierenden zellen
AT410173B (de)	2000-06-08	2003-02-25	Cistem Biotechnologies Gmbh	Antigene zusammensetzung
KR20020014459A (ko) *	2000-08-18	2002-02-25	서진호	양이온성 아미노산이 부가된 융합단백질 및 이를 이용한생물공정의 개선방법
CA2433794A1 (en) *	2001-01-05	2002-07-11	Intercell Ag	Uses for polycationic compounds as vaccine adjuvants
US7244438B2 (en)	2001-01-05	2007-07-17	Intercell Ag	Uses for polycationic compounds
EP1347776A2 (en) *	2001-01-05	2003-10-01	Intercell Biomedizinische Forschungs- und Entwicklungs AG	Anti-inflammatory use of polycationic compounds
AT410798B (de)	2001-01-26	2003-07-25	Cistem Biotechnologies Gmbh	Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
FR2824326B1 (fr) *	2001-05-04	2004-03-19	Commissariat Energie Atomique	Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
AU2002358616A1 (en) *	2001-12-07	2003-06-17	Intercell Ag	Immunostimulatory oligodeoxynucleotides
US20050221350A1 (en) *	2002-05-29	2005-10-06	Toni Weinschenk	Method for identifying immunoreactive peptides
CA2484941A1 (en)	2002-07-24	2004-02-05	Intercell Ag	Antigens encoded by alternative reading frame from pathogenic viruses
US7378234B2 (en)	2002-09-13	2008-05-27	Intercell Ag	Method for isolating hepatitis C virus peptides
CA2502414A1 (en)	2002-10-15	2004-04-29	Intercell Ag	Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
EP2287311A1 (en)	2003-03-04	2011-02-23	Intercell AG	Streptococcus pyogenes antigens
US7704514B2 (en)	2003-03-24	2010-04-27	Intercell Ag	Vaccines
US7628994B2 (en)	2003-03-31	2009-12-08	Intercell Ag	S. epidermidis antigens
US7635487B2 (en)	2003-04-15	2009-12-22	Intercell Ag	S. pneumoniae antigens
AU2004235952A1 (en)	2003-05-07	2004-11-18	Intercell Ag	Streptococcus agalactiae antigens I + II
EP2267006A1 (en)	2003-05-30	2010-12-29	Intercell AG	Enterococcus antigens
ATE489967T1 (de)	2003-07-11	2010-12-15	Intercell Ag	Hcv-vakzin
EP1722819B1 (en)	2004-03-12	2007-12-26	Intercell AG	Method for solubilising peptide mixtures
DE102004038134B4 (de)	2004-08-05	2013-07-25	Johann Wolfgang Goethe-Universität Frankfurt am Main	Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung
EP2149583B1 (en)	2004-09-24	2015-10-28	Novartis AG	Modified VP1-capsid protein of parvovirus B19
ES2327432T3 (es) *	2004-10-29	2009-10-29	Intercell Ag	Vacunas contra el vhc para pacientes con vhc cronica.
WO2006112477A1 (ja)	2005-04-20	2006-10-26	Taiho Pharmaceutical Co., Ltd.	アジュバントとしてのポリアミノ酸
EP1887084A1 (en) *	2006-08-10	2008-02-13	International Investment and Patents SA	Plasmids with immunological action
EP2059526A2 (en)	2006-09-15	2009-05-20	Intercell AG	Borrelia antigens
JP2008174490A (ja) *	2007-01-18	2008-07-31	Nitto Denko Corp	抗原性ペプチドを主成分とする薬剤
EP2360177A1 (en)	2007-05-02	2011-08-24	Intercell AG	Klebsiella antigens
KR100748265B1 (ko) *	2007-06-15	2007-08-10	(주)성문엔지니어링	공동주택에 배선된 전선의 합선방지구조
EP2511291A3 (en)	2007-06-18	2012-11-07	Intercell AG	Chlamydia antigens
KR101580660B1 (ko)	2007-08-02	2015-12-28	바이오앤드백스 파마슈티칼즈, 리미티드.	다중체 다중-에피토프 인플루엔자 백신
MX2010010569A (es) *	2008-03-27	2010-11-04	Nestec Sa	Metodos para incrementar la absorcion de peptidos, peptidomimeticos y otros sustratos de proteina de transporte gastrointestinal.
EP2356225A1 (en)	2008-12-03	2011-08-17	Protea Vaccine Technologies Ltd.	GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
EP2405938A2 (en)	2009-02-13	2012-01-18	Intercell AG	Nontypable haemophilus influenzae antigens
CN102740882A (zh) *	2009-08-27	2012-10-17	诺华有限公司	含有铝、寡核苷酸和聚阳离子的佐剂
EP2498764B1 (en)	2009-11-09	2017-09-06	Spotlight Technology Partners LLC	Fragmented hydrogels
CA2780294C (en)	2009-11-09	2018-01-16	Spotlight Technology Partners Llc	Polysaccharide based hydrogels
WO2011067758A2 (en)	2009-12-02	2011-06-09	Protea Vaccine Technologies Ltd.	Immunogenic fragments and multimers from streptococcus pneumoniae proteins
US8765148B2 (en)	2010-02-19	2014-07-01	Valneva Austria Gmbh	1C31 nanoparticles
CN103517713A (zh)	2011-02-22	2014-01-15	彼昂德瓦克斯医药有限公司	在改善的季节性和大流行性流感疫苗中的多聚体多表位多肽
RU2478399C2 (ru) *	2011-06-16	2013-04-10	Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии)	Способ получения специфического иммуномодулятора
US20140271723A1 (en) *	2013-03-15	2014-09-18	Saint Louis University	Adjuvant compositions and methods of using thereof
JP6925980B2 (ja)	2015-05-13	2021-08-25	アジェナスインコーポレイテッド	がんの処置および予防のためのワクチン
JP6710004B2 (ja) *	2016-03-15	2020-06-17	ＲｅｐｅｒｔｏｉｒｅＧｅｎｅｓｉｓ株式会社	免疫療法のためのモニタリングまたは診断ならびに治療剤の設計
KR20190034504A (ko) *	2016-05-27	2019-04-02	이투빅스 코포레이션	네오에피토프 백신 조성물 및 이의 사용 방법
BR112019006075A2 (pt)	2016-10-11	2019-06-18	Cytlimic Inc	medicamento
CN107469067B (zh) *	2017-09-05	2018-06-19	浙江大学	一种多肽及其改造体在制备免疫调节药物中的应用
JP2021522239A (ja)	2018-04-26	2021-08-30	アジェナスインコーポレイテッド	熱ショックタンパク質結合ペプチド組成物およびその使用方法
CN110870913A (zh) *	2018-08-31	2020-03-10	成都夸常奥普医疗科技有限公司	氨基酸类营养素作为疫苗佐剂的应用以及包含氨基酸营养素作为佐剂的疫苗
CN110870912A (zh) *	2018-08-31	2020-03-10	成都夸常奥普医疗科技有限公司	亚甲蓝类染料作为疫苗佐剂的应用、包含该佐剂的疫苗及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1290141A (cs)	1968-05-31	1972-09-20
US4847240A (en) *	1978-01-16	1989-07-11	The Trustees Of Boston University	Method of effecting cellular uptake of molecules
US4728639A (en) *	1982-07-27	1988-03-01	University Of Tennessee Research Corporation	Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant
US6022544A (en) *	1983-01-24	2000-02-08	The John Hopkins University	Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US4956273A (en) *	1985-10-24	1990-09-11	Southwest Foundation For Biomedical Research	Synthetic peptides and method of use for diagnosis and vaccination for AIDS and ARC
IL82841A (en) *	1986-06-13	1992-11-15	Oncogen	Ligands and in vitro methods for augmenting b-cell proliferation
DE68925660T2 (de) *	1988-06-10	1996-09-26	United Biomedical Inc	Peptidfragmente von HIV
JP2955314B2 (ja) *	1988-10-27	1999-10-04	リージェンツ・オブ・ザ・ユニバーシティー・オブ・ミネソタ	Ｉｌ―２含有リポソーム免疫アジュバント
EP0510054A1 (en)	1990-01-05	1992-10-28	United Biomedical, Inc.	Hiv-1 core protein fragments
US6235525B1 (en)	1991-05-23	2001-05-22	Ludwig Institute For Cancer Research	Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
US5342774A (en)	1991-05-23	1994-08-30	Ludwig Institute For Cancer Research	Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
ATE260679T1 (de)	1992-04-03	2004-03-15	Univ California	Selbstorganisierendes system zur verabreichung von polynukleotiden enthaltend ein amphiphatisches peptid
ATE280180T1 (de)	1992-08-31	2004-11-15	Ludwig Inst Cancer Res	Vom mage-3-gen abgeleitetes und von hla-a1 präsentiertes, isoliertes nonapeptid und dessen anwendungen
US5571711A (en) *	1993-06-17	1996-11-05	Ludwig Institute For Cancer Research	Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors
US5409703A (en) *	1993-06-24	1995-04-25	Carrington Laboratories, Inc.	Dried hydrogel from hydrophilic-hygroscopic polymer
CZ5191U1 (cs) *	1993-07-12	1996-09-12	Aliatros Medical, A.S.	Farmaceutický prostředek pro imunomodulační a adjuvantní léčbu
JP2828391B2 (ja) *	1993-10-29	1998-11-25	東燃株式会社	オリゴ糖を表面に有するリポソーム
US6660276B1 (en) *	1994-02-16	2003-12-09	The University Of Virginia Patent Foundation	Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
US6001809A (en) *	1994-07-11	1999-12-14	Elan Pharmaceuticals, Inc.	Inhibitors of leukocyte adhesion
UY24367A1 (es) †	1995-11-23	2000-10-31	Boehringer Ingelheim Int	Vacunas contra tumores y procedimiento para su produccion
RS50101B (sr)	1996-02-24	2009-01-22	Boehringer Ingelheim International Gmbh.,	Farmaceutski preparati za imunomodulaciju

1997
- 1997-02-20 RS YUP-62/97A patent/RS50101B/sr unknown
- 1997-02-20 CO CO97009092A patent/CO4600681A1/es unknown
- 1997-02-21 PL PL97328455A patent/PL189413B1/pl unknown
- 1997-02-21 AR ARP970100701A patent/AR005945A1/es active IP Right Grant
- 1997-02-21 US US09/125,672 patent/US7105162B1/en not_active Expired - Fee Related
- 1997-02-21 CN CNB971925186A patent/CN1177610C/zh not_active Expired - Fee Related
- 1997-02-21 IL IL12536197A patent/IL125361A/en not_active IP Right Cessation
- 1997-02-21 CA CA2243559A patent/CA2243559C/en not_active Expired - Fee Related
- 1997-02-21 AU AU18759/97A patent/AU722264B2/en not_active Ceased
- 1997-02-21 JP JP52980697A patent/JP4184433B2/ja not_active Expired - Fee Related
- 1997-02-21 MY MYPI97000683A patent/MY119276A/en unknown
- 1997-02-21 EE EE9800255A patent/EE04481B1/xx unknown
- 1997-02-21 SK SK1145-98A patent/SK284582B6/sk not_active IP Right Cessation
- 1997-02-21 DK DK97905068T patent/DK0881906T4/da active
- 1997-02-21 DE DE59711873T patent/DE59711873D1/de not_active Expired - Lifetime
- 1997-02-21 WO PCT/EP1997/000828 patent/WO1997030721A1/de active IP Right Grant
- 1997-02-21 PT PT97905068T patent/PT881906E/pt unknown
- 1997-02-21 BR BR9707694A patent/BR9707694A/pt not_active IP Right Cessation
- 1997-02-21 CZ CZ19982689A patent/CZ295396B6/cs not_active IP Right Cessation
- 1997-02-21 AT AT97905068T patent/ATE274350T1/de active
- 1997-02-21 EP EP97905068A patent/EP0881906B2/de not_active Expired - Lifetime
- 1997-02-21 KR KR10-1998-0706339A patent/KR100457647B1/ko not_active IP Right Cessation
- 1997-02-21 SI SI9730672T patent/SI0881906T2/sl unknown
- 1997-02-21 RO RO98-01305A patent/RO119344B1/ro unknown
- 1997-02-21 TR TR1998/01649T patent/TR199801649T2/xx unknown
- 1997-02-21 NZ NZ332020A patent/NZ332020A/en not_active IP Right Cessation
- 1997-02-21 HR HR970100A patent/HRP970100B1/xx not_active IP Right Cessation
- 1997-02-21 ES ES97905068T patent/ES2225951T5/es not_active Expired - Lifetime
- 1997-02-21 HU HU9901186A patent/HU224410B1/hu not_active IP Right Cessation
- 1997-02-24 PE PE1997000130A patent/PE55398A1/es not_active IP Right Cessation
- 1997-02-24 TW TW086102221A patent/TW585774B/zh not_active IP Right Cessation
- 1997-02-24 ID IDP970541A patent/ID16038A/id unknown
1998
- 1998-08-21 BG BG102714A patent/BG63682B1/bg active Active
- 1998-08-21 NO NO983850A patent/NO983850L/no not_active Application Discontinuation
1999
- 1999-05-25 HK HK99102360A patent/HK1017257A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL328455A1 (en)	1999-02-01
BG63682B1 (bg)	2002-09-30
CO4600681A1 (es)	1998-05-08
PT881906E (pt)	2004-10-29
BG102714A (en)	1999-06-30
ID16038A (id)	1997-08-28
CA2243559A1 (en)	1997-08-28
ES2225951T3 (es)	2005-03-16
BR9707694A (pt)	1999-07-27
DE59711873D1 (de)	2004-09-30
HRP970100B1 (en)	2001-04-30
SI0881906T2 (sl)	2009-06-30
AU1875997A (en)	1997-09-10
RS50101B (sr)	2009-01-22
SK284582B6 (sk)	2005-07-01
EP0881906A1 (de)	1998-12-09
RO119344B1 (ro)	2004-08-30
IL125361A (en)	2002-08-14
EE9800255A (et)	1999-02-15
ES2225951T5 (es)	2009-06-15
AU722264B2 (en)	2000-07-27
HU224410B1 (hu)	2005-08-29
IL125361A0 (en)	1999-03-12
KR19990082601A (ko)	1999-11-25
NO983850D0 (no)	1998-08-21
CA2243559C (en)	2011-08-09
JP2000506125A (ja)	2000-05-23
CZ268998A3 (cs)	1999-07-14
EE04481B1 (et)	2005-06-15
DK0881906T4 (da)	2009-05-25
PE55398A1 (es)	1998-09-22
NZ332020A (en)	2000-02-28
CN1177610C (zh)	2004-12-01
HK1017257A1 (en)	1999-11-19
YU6297A (sh)	1999-09-27
TR199801649T2 (xx)	1998-12-21
HRP970100A2 (en)	1998-04-30
CN1211926A (zh)	1999-03-24
EP0881906B1 (de)	2004-08-25
AR005945A1 (es)	1999-07-21
EP0881906B2 (de)	2009-02-04
SI0881906T1 (en)	2004-12-31
CZ295396B6 (cs)	2005-08-17
HUP9901186A2 (hu)	1999-07-28
HUP9901186A3 (en)	2001-01-29
SK114598A3 (en)	1999-06-11
MY119276A (en)	2005-04-30
WO1997030721A1 (de)	1997-08-28
US7105162B1 (en)	2006-09-12
DK0881906T3 (da)	2004-12-20
PL189413B1 (pl)	2005-08-31
TW585774B (en)	2004-05-01
ATE274350T1 (de)	2004-09-15
KR100457647B1 (ko)	2005-06-20
JP4184433B2 (ja)	2008-11-19

Publication	Publication Date	Title
NO983850D0 (no)	1998-08-21	Farmas°ytisk blanding for immunomodulering basert pÕ peptider og adjuvanser
NO992779L (no)	1999-08-19	OB-fusjonsproteinpreparater og fremgangsmåte
DE69722620D1 (de)	2003-07-10	Nicht-waessrige protische peptidzubereitungen
NO20000700D0 (no)	2000-02-11	Interleukin-18-proteiner samt fremstilling og anvendelse derav
FI974429L (fi)	1997-12-05	Suspendoituja peptidi/proteiinivalmisteita
IS4496A (is)	1997-06-04	Úðablöndur úr peptíðum og próteinum
DK1035865T3 (da)	2008-02-04	HIV-1-Tat eller derivater deraf til profylaktisk og terapeutisk vaccination
IL118059A0 (en)	1996-08-04	Recombinant obese proteins
FI960584L (fi)	1996-02-08	Terapeuttisia peptidijohdannaisia
NO20011801D0 (no)	2001-04-09	Adjuvantsystemer og vaksiner
NO992427D0 (no)	1999-05-20	Farmas°ytisk blanding
NO985680D0 (no)	1998-12-04	Peptidderivater
NO983849L (no)	1998-10-21	Peptidderivater
NO990836D0 (no)	1999-02-22	Antitrombotiske azacykloalkylalkanoylpeptider og pseudopeptider
FI963334L (fi)	1996-08-27	Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
NO992091D0 (no)	1999-04-29	Farmas°ytiske blandinger inneholdende lamivudin og zidovudin
ATA1972000A (de)	2003-10-15	Rekombinant hergestelltes menschliches intestinales npt2b-polypeptid
DE69427363D1 (de)	2001-07-05	Plättchenaggregationsinhibierende peptide
GB2331521B (en)	2000-09-06	Vaccine preparations
NO20005547D0 (no)	2000-11-03	Myelinbasiske proteinpeptider og anvendelser derav
AU4489896A (en)	1996-07-24	Avian recombinant live vaccine
NO941950D0 (no)	1994-05-25	Hemoregulerende peptider
NO985572L (no)	1999-01-26	Substituerte amidinobenzenderivater og medisinske preparater derav
DE69434900D1 (de)	2007-02-08	Menschliche chemokin-polypeptide
ITMI922675A1 (it)	1994-05-23	Peptidi immunogenici

Legal Events

Date	Code	Title	Description
2007-08-20	FC2A	Withdrawal, rejection or dismissal of laid open patent application